Obsidian Therapeutics, Inc. Common Stock Financial Flexibility Index
Obsidian Therapeutics, Inc. Common Stock financial flexibility index. Obsidian Therapeutics, Inc. Common Stock (OBX) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-22.01 Million (operating CF $-22.01 Million minus capex $0.00) represents 0% of total liabilities ($346.33 Million). Check Obsidian Therapeutics, Inc. Common Stock liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Obsidian Therapeutics, Inc. Common Stock (2024–2025)
Financial flexibility index of Obsidian Therapeutics, Inc. Common Stock from 2024 to 2025. Historical Financial Flexibility Index trend for Obsidian Therapeutics, Inc. Common Stock across 2 annual periods. Explore OBX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Obsidian Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2024–2025)
Obsidian Therapeutics, Inc. Common Stock financial flexibility index by year from 2024 to 2025. Year-by-year free cash flow to debt coverage for Obsidian Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see OBX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.25x | $-90.32 Million | $-90.39 Million | $354.62 Million | ▼ -22.9% |
| 2024 | -0.21x | $-74.22 Million | $-75.00 Million | $358.14 Million | — |